7-116537771-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001753.5(CAV1):c.195+11082G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.669 in 151,970 control chromosomes in the GnomAD database, including 35,799 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.67 ( 35799 hom., cov: 31)
Consequence
CAV1
NM_001753.5 intron
NM_001753.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.89
Publications
13 publications found
Genes affected
CAV1 (HGNC:1527): (caveolin 1) The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1.[provided by RefSeq, Mar 2010]
CAV1 Gene-Disease associations (from GenCC):
- pulmonary arterial hypertensionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- partial lipodystrophy, congenital cataracts, and neurodegeneration syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- pulmonary hypertension, primary, 3Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- congenital generalized lipodystrophy type 3Inheritance: AD, AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, G2P
- heritable pulmonary arterial hypertensionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Berardinelli-Seip congenital lipodystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- amyotrophic lateral sclerosisInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.762 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAV1 | NM_001753.5 | c.195+11082G>A | intron_variant | Intron 2 of 2 | ENST00000341049.7 | NP_001744.2 | ||
CAV1 | NM_001172895.1 | c.102+11082G>A | intron_variant | Intron 2 of 2 | NP_001166366.1 | |||
CAV1 | NM_001172896.2 | c.102+11082G>A | intron_variant | Intron 1 of 1 | NP_001166367.1 | |||
CAV1 | NM_001172897.2 | c.102+11082G>A | intron_variant | Intron 2 of 2 | NP_001166368.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.669 AC: 101655AN: 151852Hom.: 35788 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
101655
AN:
151852
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.669 AC: 101697AN: 151970Hom.: 35799 Cov.: 31 AF XY: 0.670 AC XY: 49737AN XY: 74274 show subpopulations
GnomAD4 genome
AF:
AC:
101697
AN:
151970
Hom.:
Cov.:
31
AF XY:
AC XY:
49737
AN XY:
74274
show subpopulations
African (AFR)
AF:
AC:
17948
AN:
41406
American (AMR)
AF:
AC:
11257
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
2898
AN:
3472
East Asian (EAS)
AF:
AC:
4031
AN:
5168
South Asian (SAS)
AF:
AC:
3578
AN:
4804
European-Finnish (FIN)
AF:
AC:
7433
AN:
10554
Middle Eastern (MID)
AF:
AC:
218
AN:
294
European-Non Finnish (NFE)
AF:
AC:
52149
AN:
67986
Other (OTH)
AF:
AC:
1485
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1555
3110
4666
6221
7776
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
796
1592
2388
3184
3980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2613
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.